Company: GRCE
Filing Date: 2025-07-28
Form Type: DEF 14A
Source: 0001140361-25-027456
Chunk: 12

Company: Grace Therapeutics, Inc.
Filing Date: 2025-07-28
Form: DEF 14A
Chunk 12
---
 or, if you submit a proxy over the internet or by telephone, you will need to enter each of your Control Numbers. |

| Q: | How will proxies be solicited and who is paying for the cost of the proxy solicitation? |

| A: | We will pay for the entire cost of soliciting proxies, including the printing, handling and mailing of the Annual Meeting materials. In addition to these proxy materials, our directors and certain executive officers may, without additional remuneration, solicit proxies in person, by telephone, or by other means of communication. We may also reimburse brokers, banks and other nominees for their reasonable out-of-pocket expenses for forwarding proxy materials to our stockholders, if any. |

| Q: | Who is the independent registered public accounting firm, and will it be represented at the Annual Meeting? |

| Q: | Why are we being asked to ratify the appointment of KPMG LLP? |

| A: | Although stockholder approval of the Audit Committee’s appointment of KPMG LLP as our independent registered public accounting firm is not required, we believe that it is advisable to give stockholders an opportunity to ratify this appointment as a matter of good corporate practice. If the stockholders fail to ratify the appointment, the Audit Committee will reconsider its appointment of KPMG LLP, but will not be required to take any action. Even if the appointment is ratified, the Audit Committee in its discretion may direct the appointment of a different independent registered public accounting firm at any time during the year if the Audit Committee determines that such a change would be in the best interests of the Company and its stockholders. |

| Q: | How can I find out the results of the voting at the Annual Meeting? |

| A: | Preliminary voting results will be announced at the Annual Meeting. In addition, final voting results will be reported in a Current Report on Form 8-K, which we will file with the Securities and Exchange Commission (“SEC”) on EDGAR at www.sec.gov within four business days of the Annual Meeting, and will also be filed with the Canadian provincial securities regulators on SEDAR+ at www.sedarplus.ca. |

6

TABLE OF CONTENTS PROPOSAL NO. 1 ELECTION OF FIVE DIRECTORS Size of the Board Our Board currently consists of five directors, each serving a one-year term that will expire at the 2025 Annual Meeting. Director Nominees Our Board, upon the recommendation of the Nominating and Corporate Governance Committee of